Mail & Guardian
Mail & Guardian

Anti Hiv Injection

latest news & developments
To end Aids by 2043, the South African government says it could get a group of local pharmaceutical companies to make generic shots of lenacapavir from 2027 onwards. There is, however, a hitch. None of the companies that will be involved have a licence to make the jab. (Julia Koblitz/ Unsplash)
AARON MOTSOALEDI

SA wants to make its own six-monthly HIV prevention jabs by 2027. But there’s a hitch

None of the companies that will be involved have a licence from the inventor of Lenacapavir, Gilead Sciences, to make the jab

  • Mia Malan
9 min read
One in 10 clinics in South Africa will start to hand out a twice-a-year anti-HIV jab as early as February. The country’s medicines regulator, Sahpra, says it’s on track to announce its registration decision within the next few days, by the end of October. So who should get LEN first? (Anna-Maria van Niekerk)
AARON MOTSOALEDI

The six-monthly anti-HIV jab could be in 360 clinics by February. Who should get the first doses?

The country’s medicines regulator Sahpra says it’s on track to announce its registration decision by the end of October

  • Mia Malan
10 min read
CAB-LA, a long-acting HIV prevention shot is currently being trailed in 3 200 women across Sub-Saharan Africa. (Yolanda Mdzeke, Bhekisisa)
ANTI HIV INJECTION

Anti-HIV injection to be made in SA

CAB-LA will be made at Indian drug company Cipla’s Benoni and Durban plants, but a starting date for production has not yet been announced

  • Zano Kunene
10 min read